caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1770758617

Rajeswari ChellappahM.D.

Hematology-OncologyRoseville, CAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Rajeswari Chellappah's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 11 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
SUTTER VALLEY HOSPITALS94840
KIM, MIN HUI2590
Bijan Bijan
Diagnostic Radiology · Sacramento, CA
2397
POUNDS, THOMAS1974
Frederick Weiland
Nuclear Medicine · Roseville, CA
1427
NPI 12957874551350
Penny Vandestreek
Nuclear Medicine · Roseville, CA
1331
Charles Mcdonnell
Diagnostic Radiology · Sacramento, CA
1226
Nancy Laurence
Diagnostic Radiology · Sacramento, CA
1126
Christine Chao
Interventional Radiology · Sacramento, CA
1143
Dennis Mcdonald
Diagnostic Radiology · Sacramento, CA
1119
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
472
Unique beneficiaries
—
Total services
888
Distinct HCPCS
5
Medicare payment
$112K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 957 Hematology-Oncology providers in CA — below median (cohort median 4,173).
PRESCRIBING · PART D · 2024
Total Rx claims
977
Beneficiaries
—
Total drug cost
$645K
Distinct drugs
30
Brand share
17.4%
Top prescribed drugs
Anastrozole136 claims
Letrozole98 claims
Potassium Chloride65 claims
Gabapentin58 claims
Apixaban57 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$24
Payment records
1
By payment type
Food and Beverage$24